Crossmark

Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13054-017-1695-0

Published Online: 2017-05-17

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Agus, A. https://orcid.org/0000-0001-9839-6282
Hulme, C.

Verghis, R. M.

McDowell, C.

Jackson, C.

O’Kane, C. M.

Laffey, J. G.

McAuley, D. F.
Funding

Funding for this research was provided by:

Efficacy and Mechanism Evaluation Programme (08/99/08)

Health Research Board (HRA_POR-2010-131)